Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02265965 · ClinicalTrials.gov registry record · Phase 4
Trial of IV NTG for CD After Second Stage Arrest for the Prevention of Uterine Extension
A Phase 4 study of Prolonged Second Stage of Labor, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT02265965: Completed Phase 4 study of Prolonged Second Stage of Labor, sponsored by University of California, San Francisco.
NCT02265965 is a Phase 4 study of Prolonged Second Stage of Labor that has completed, run by University of California, San Francisco. The registered enrollment target is 18 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02265965, a Phase 4 study of Prolonged Second Stage of Labor, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized controlled clinical trial of IV nitroglycerin at cesarean delivery for second stage arrest of descent to prevent or uterine extension at the hysterectomy site.
Primary Outcome
Obstetrician determined whether the subject had an uterine extension.
Conditions Studied
Interventions
- DRUG intravenous nitroglycerin
Study Locations (1)
California
- University California San Francisco-Labor and Delivery - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2015-10 |
| Est. Completion | 2018-07-01 |
| Phase | Phase 4 |
What the finished NCT02265965 record still lists
NCT02265965 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Prolonged Second Stage of Labor appearing as the primary indexed condition, and to 1 intervention - of which intravenous nitroglycerin is the first listed.
NCT02265965 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02265965 about?
NCT02265965 is a clinical study titled "Trial of IV NTG for CD After Second Stage Arrest for the Prevention of Uterine Extension". Randomized controlled clinical trial of IV nitroglycerin at cesarean delivery for second stage arrest of descent to prevent or uterine extension at the hysterectomy site.
What is the current status of trial NCT02265965?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2015-10. Estimated completion is 2018-07-01.
What conditions does trial NCT02265965 study?
This clinical trial studies the following conditions: Prolonged Second Stage of Labor.
What interventions are being tested in trial NCT02265965?
The interventions under investigation include: intravenous nitroglycerin (DRUG).
Who is sponsoring clinical trial NCT02265965?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02265965 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02265965's enrollment target sits among peer trials
18 1842nd of 2000 higher than 147 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia